期刊文献+

序贯诱导治疗急性早幼粒细胞白血病长期生存分析 被引量:1

Long-term survival analysis of acute promyelocytic leukemia treated with sequential induction chemotherapy
原文传递
导出
摘要 近年来急性早幼粒细胞白血病(APL)的分子学发病机制逐渐被阐明,其治疗经历了蒽环类药物为主的联合化疗、全反式维甲酸(ATRA)和亚砷酸(ATO)治疗3个阶段。
出处 《临床血液学杂志》 CAS 2013年第3期331-333,共3页 Journal of Clinical Hematology
关键词 早幼粒细胞白血病 急性 诱导 化学治疗 生存 acute prornyelocytic leukemia induction chemotherapy survival
  • 相关文献

参考文献16

  • 1FENAUX P,CASTAIGNE S,DOMBRET H,et al.All-tranvS retinoic acid followed by intensive chemo-therapy gives a high complete remission rate and mayprolong remissions in newly diagnosed acute promye-locytic leukemia:a pilot study on 26 cases[J]. Blood,1992,80:2176-2181.
  • 2全反式维甲酸治疗544例急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1992,13(3):135-137. 被引量:94
  • 3MUINDI J,FRANKEL S R, MILLER WH Jr,et al.Continuous treatment with all-trans retinoic acid cau-ses a progressive reduction in plasma drug concentra-tions: implications for relap'se and retinoid “ resist-ance” in patients with acute promyelocytic leukemia[J]. Blood,1992,79:299-303.
  • 4HUANG C UDENG M L,GUO R J,et al. A studyon the induction of differentiation of human leukemiccelLs by harringtonine combined with cytarabine[J].Leukemia, 1988,2:518 — 522.
  • 5FENAUX P,CASTAIGNE S,CHOMIENNE C,et al.All tranvS retinoic acid treatment for patients with a-cute promyelocytic leukemia [ J ]. Leukemia, 1992,6Suppl 1 :64 — 66.
  • 6SANZ M A,LO COCO F, MARTIN G,et al. Defini-tion of relapse risk and role of nonanthracycline drugsfor consolidation in patients with acute promyelocyticleukemia: A joint study of the PETHEMA andG1MEMA cooperative groups [J]. Blood, 2000 , 96:1247-1253.
  • 7PARK J H,QIAO B,PANAGEAS K S,et al. Earlydeath rate in acute promyelocytic leukemia remainshigh despite all-trans retinoic acid [ J]. Blood, 2011,118:1248—1254.
  • 8MONTESINOS P,BERGUA J M,VEILENGA E,etal. Differentiation syndrome in patients with acutepromyelocytic leukemia treated with all-trans retinoicacid and anthracycline chemotherapy: characteristics,outcome,and prognostic factors[J]. Blood,2009,113 :775-783.
  • 9黄昌亮,郝森量.小剂量三尖杉酯碱阿糖胞苷联合治疗急非淋白血病的疗效预测[J].中华血液学杂志,1991,12(8):430-431. 被引量:2
  • 10梁英民.佟瑞芝,黄昌亮.三尖杉酯碱与阿糖胞苷在诱导HL-60细胞分化中的协同作用[J].中华血液学杂志,1992,13(3):144-144.

二级参考文献12

  • 1Burnett AK, Milligan D, Prentice AG, et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer, 2007, 109: 1114-1124.
  • 2Huang CL, Deng ML, Guo R J, et al. A study on the induction of differentiation of human leukemic ceils by harringtonine combined with cytarabine. Leukemia, 1988, 2:518-522.
  • 3Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine: history, current research, and future direction. Cancer, 2001, 92: 1591-1605.
  • 4Boyd AW, Sullivan JR. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine. Blood, 1984, 63: 384-392.
  • 5Latagliata R, Breccia M, Pulsoni A, et al. Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs induction. Leuk Lymphoma, 2000, 36: 539-541.
  • 6Rizzieri DA, O'Brien JA, Broadwater G, et al.Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia. Cancer, 2009, 115: 2922-2929.
  • 7Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N EngI J Med, 2009, 361: 1249-1259.
  • 8Mayer R J, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med, 1994, 331: 896-903.
  • 9卞寿庚,中华内科杂志,1990年,20卷,22页
  • 10陈子兴,中华血液学杂志,1990年,11卷,121页

共引文献95

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部